INVO Fertility, Inc. (IVF)
About INVO Fertility, Inc.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic; The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell; and The Therapeutics segment consisting of financial information relating to acquired subsidiary, NTI.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $6.8M
- Net income
- -$23.3M
- Total assets
- $20.2M
- Market cap
- $2.8M
- Gross margin
- 99.6%
- Operating margin
- -105.8%
- Net margin
- -318.5%
Source: SEC EDGAR · updated Jun 8, 2026
Financial statements
Income statement
- Revenue
- $6.8M
- Cost of revenue
- $30.6K
- Gross profit
- $6.8M
- Operating expenses
- $14.0M
- Operating income
- -$7.2M
- Income tax
- -$150.4K
- Net income
- -$21.8M
- EPS (basic)
- $-214.64
- EPS (diluted)
- $-214.64
Balance sheet
- Total assets
- $20.2M
- Current assets
- $2.8M
- Total liabilities
- $13.0M
- Current liabilities
- $10.3M
- Shareholders’ equity
- $7.2M
Cash flow
- Operating cash flow
- -$7.0M
- Investing cash flow
- -$2.7M
- Financing cash flow
- $11.1M
- Net cash flow
- $1.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.8M
- EPS (diluted)
- $-214.64
- Shares outstanding
- 2.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 11, 2008
INVO Fertility, Inc. (IVF) Stock Price
- Reported a net loss of $23.3M in FY2025.
- Gross margin of 99.6%, net margin -318.5%.
- Trading 99% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review INVO Fertility, Inc..
Write a review
News about INVO Fertility, Inc.
News & sentiment via Polygon.io
INVO Fertility, Inc.: frequently asked questions
Is INVO Fertility, Inc. an American company?
INVO Fertility, Inc. is a US-based company headquartered in Sarasota, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is INVO Fertility, Inc. headquartered?
INVO Fertility, Inc. is headquartered in Sarasota, Florida, United States.
Is INVO Fertility, Inc. publicly traded?
Yes — INVO Fertility, Inc. is a publicly traded company. Its stock trades under the ticker symbol IVF on the NASDAQ.
What does INVO Fertility, Inc. do?
INVO Fertility, Inc. is an American Medical Devices company in the Health & Beauty sector.
